<VariationArchive VariationID="98821" VariationName="NM_000329.3(RPE65):c.1067del (p.Asn356fs)" VariationType="Deletion" Accession="VCV000098821" Version="13" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-05-08" DateCreated="2014-02-20" MostRecentSubmission="2024-05-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="104711" VariationID="98821">
      <GeneList>
        <Gene Symbol="RPE65" FullName="retinoid isomerohydrolase RPE65" GeneID="6121" HGNC_ID="HGNC:10294" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="68428822" stop="68449954" display_start="68428822" display_stop="68449954" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="68894506" stop="68915641" display_start="68894506" display_stop="68915641" Strand="-" />
          </Location>
          <OMIM>180069</OMIM>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000329.3(RPE65):c.1067del (p.Asn356fs)</Name>
      <CanonicalSPDI>NC_000001.11:68438247:TTTTTTTT:TTTTTTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p31.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="68438248" stop="68438248" display_start="68438248" display_stop="68438248" variantLength="1" positionVCF="68438247" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="68903931" stop="68903931" display_start="68903931" display_stop="68903931" variantLength="1" positionVCF="68903930" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>NM_000329.3(RPE65):c.1067del</Name>
        <Name>p.Asn356fs</Name>
      </OtherNameList>
      <ProteinChange>N356fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.68903938del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.68903938del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.68438255del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.68438255del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008472.2" sequenceAccession="NG_008472" sequenceVersion="2" change="g.16712del">
            <Expression>NG_008472.2:g.16712del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000329.3" sequenceAccession="NM_000329" sequenceVersion="3" change="c.1067del" MANESelect="true">
            <Expression>NM_000329.3:c.1067del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000320.1" sequenceAccession="NP_000320" sequenceVersion="1" change="p.Asn356fs">
            <Expression>NP_000320.1:p.Asn356fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000329.2" sequenceAccession="NM_000329" sequenceVersion="2" change="c.1067del">
            <Expression>NM_000329.2:c.1067del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000329.3" sequenceAccession="NM_000329" sequenceVersion="3" change="c.1067delA" MANESelect="true">
            <Expression>NM_000329.3:c.1067delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA226477" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="180069.0001" DB="OMIM" />
        <XRef Type="rs" ID="281865520" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000329.3(RPE65):c.1067del (p.Asn356fs) AND Leber congenital amaurosis 2" Accession="RCV000013992" Version="20">
        <ClassifiedConditionList TraitSetID="3569">
          <ClassifiedCondition DB="MedGen" ID="C1859844">Leber congenital amaurosis 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-10" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000329.3(RPE65):c.1067del (p.Asn356fs) AND not provided" Accession="RCV000085145" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000329.3(RPE65):c.1067del (p.Asn356fs) AND multiple conditions" Accession="RCV001383022" Version="6">
        <ClassifiedConditionList TraitSetID="9541">
          <ClassifiedCondition DB="MedGen" ID="C1859844">Leber congenital amaurosis 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3151086">Retinitis pigmentosa 20</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000329.3(RPE65):c.1067del (p.Asn356fs) AND Leber congenital amaurosis" Accession="RCV001826772" Version="1">
        <ClassifiedConditionList TraitSetID="7918">
          <ClassifiedCondition DB="MedGen" ID="C0339527">Leber congenital amaurosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-03-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000329.3(RPE65):c.1067del (p.Asn356fs) AND RPE65-related recessive retinopathy" Accession="RCV002466426" Version="2">
        <ClassifiedConditionList TraitSetID="81319">
          <ClassifiedCondition DB="MedGen" ID="CN305526">RPE65-related recessive retinopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2024-04-22" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-04-22" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2014-02-20" MostRecentSubmission="2024-05-07">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18632300</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9326927</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9326941</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9501220</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9843205</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/daeb1902-db11-4ce0-a723-fc1f96265b49</URL>
        </Citation>
        <DescriptionHistory Dated="2019-01-25">
          <Description>not provided</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-01-25">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="81319" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="61324" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">RPE65-related recessive retinopathy</ElementValue>
                <XRef ID="MONDO:0100368" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Recessive RPE65 retinopathy</ElementValue>
              </Name>
              <XRef ID="CN305526" DB="MedGen" />
              <XRef ID="MONDO:0100368" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3569" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5384" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Leber congenital amaurosis 2</ElementValue>
                <XRef ID="Leber+congenital+amaurosis+type+2/4136" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008765" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AMAUROSIS CONGENITA OF LEBER II</ElementValue>
                <XRef Type="MIM" ID="204100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RPE65-Related Leber Congenital Amaurosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amaurosis congenita of Leber, type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LCA2</ElementValue>
                <XRef Type="MIM" ID="204100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="636" />
                <XRef ID="636" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">RPE65-related Leber congenital amaurosis / early-onset severe retinal dystrophy (RPE65-LCA/EOSRD) is a severe inherited retinal degeneration (IRD) with a typical presentation between birth and age five years. While central vision varies, the hallmark of this disorder is the presence of severe visual impairment with a deceptively preserved retinal structure. Vision is relatively stable in the first decade of life, but begins to decline in adolescence. Most affected individuals are legally blind (visual acuity 20/200 and/or visual fields extending &lt;20 degrees from fixation) by age 20 years. After age 20 years, visual acuity declines further and by the fourth decade all affected individuals are legally blind and many have complete loss of vision (i.e., no light perception). Milder disease phenotypes have been described in individuals with hypomorphic alleles.</Attribute>
                <XRef ID="NBK549574" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000506299" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518813" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500417" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502495" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30285347</ID>
                <ID Source="BookShelf">NBK531510</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31725251</ID>
                <ID Source="BookShelf">NBK549574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="65" DB="Orphanet" />
              <XRef ID="C1859844" DB="MedGen" />
              <XRef ID="MONDO:0008765" DB="MONDO" />
              <XRef Type="MIM" ID="204100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7918" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16716" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Leber congenital amaurosis</ElementValue>
                <XRef ID="MONDO:0018998" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS204000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital retinal blindness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leber's amaurosis</ElementValue>
                <XRef ID="Leber+congenital+amaurosis/4130" DB="Genetic Alliance" />
                <XRef ID="193413001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LCA</ElementValue>
                <XRef Type="MIM" ID="204000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CRB</ElementValue>
                <XRef Type="MIM" ID="204000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="634" />
                <XRef ID="634" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="65" DB="Orphanet" />
              <XRef ID="C0339527" DB="MedGen" />
              <XRef ID="D057130" DB="MeSH" />
              <XRef ID="MONDO:0018998" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS204000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9541" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="6587" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinitis pigmentosa 20</ElementValue>
                <XRef ID="Retinitis+Pigmentosa+20/6259" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013425" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RP 20</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RP20</ElementValue>
                <XRef Type="MIM" ID="613794" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10404" />
                <XRef ID="10404" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301590</ID>
                <ID Source="BookShelf">NBK1417</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="791" DB="Orphanet" />
              <XRef ID="C3151086" DB="MedGen" />
              <XRef ID="MONDO:0013425" DB="MONDO" />
              <XRef Type="MIM" ID="613794" DB="OMIM" />
            </Trait>
            <Trait ID="5384" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Leber congenital amaurosis 2</ElementValue>
                <XRef ID="Leber+congenital+amaurosis+type+2/4136" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008765" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AMAUROSIS CONGENITA OF LEBER II</ElementValue>
                <XRef Type="MIM" ID="204100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RPE65-Related Leber Congenital Amaurosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amaurosis congenita of Leber, type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LCA2</ElementValue>
                <XRef Type="MIM" ID="204100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="636" />
                <XRef ID="636" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">RPE65-related Leber congenital amaurosis / early-onset severe retinal dystrophy (RPE65-LCA/EOSRD) is a severe inherited retinal degeneration (IRD) with a typical presentation between birth and age five years. While central vision varies, the hallmark of this disorder is the presence of severe visual impairment with a deceptively preserved retinal structure. Vision is relatively stable in the first decade of life, but begins to decline in adolescence. Most affected individuals are legally blind (visual acuity 20/200 and/or visual fields extending &lt;20 degrees from fixation) by age 20 years. After age 20 years, visual acuity declines further and by the fourth decade all affected individuals are legally blind and many have complete loss of vision (i.e., no light perception). Milder disease phenotypes have been described in individuals with hypomorphic alleles.</Attribute>
                <XRef ID="NBK549574" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000506299" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518813" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500417" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502495" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30285347</ID>
                <ID Source="BookShelf">NBK531510</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31725251</ID>
                <ID Source="BookShelf">NBK549574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="65" DB="Orphanet" />
              <XRef ID="C1859844" DB="MedGen" />
              <XRef ID="MONDO:0008765" DB="MONDO" />
              <XRef Type="MIM" ID="204100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="34239" SubmissionDate="2017-01-17" DateLastUpdated="2015-10-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="180069.0001_LEBER CONGENITAL AMAUROSIS 2" title="RPE65, 1-BP DEL, 1067A_LEBER CONGENITAL AMAUROSIS 2" />
        <ClinVarAccession Accession="SCV000034239" DateUpdated="2015-10-11" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs, aged 20 years and 13 years, with Leber congenital amaurosis (LCA2; 204100), Marlhens et al. (1997) found compound heterozygosity for a 1067delA mutation in a stretch of consecutive adenine residues; and a 700T-C transition in a CpG site that resulted in a nonsense mutation, R234X (180069.0002). These mutations were inherited from the mother and father, respectively, who were clinically unaffected. Fundus examination of the patients showed a number of yellowish spots in the outer layers of the retina. In addition, few pigmentary deposits, moderate narrowing of retinal vessels and pallor of the optic disc revealed a lesser-than-expected degree of degeneration. This was similar to some cases of Leber congenital amaurosis in infants, in whom an undetectable electroretinographic response contrasts with an almost normal ophthalmoscopic appearance. Therefore, the severely reduced sight of the 2 sibs was thought to be due partly to dysfunctioning photoreceptors rather than to loss of photoreceptors.</Attribute>
              <Citation>
                <ID Source="PubMed">9326927</ID>
              </Citation>
              <XRef DB="OMIM" ID="204100" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPE65" />
          </GeneList>
          <Name>RPE65, 1-BP DEL, 1067A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1067A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="180069.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LEBER CONGENITAL AMAUROSIS 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="9755782" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-07" DateCreated="2024-05-07">
        <ClinVarSubmissionID localKey="daeb1902-db11-4ce0-a723-fc1f96265b49" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV005038768" DateUpdated="2024-05-07" DateCreated="2024-05-07" Type="SCV" Version="1" SubmitterName="ClinGen Leber Congenital Amaurosis/early Onset Retinal Dystrophy Variant Curation Expert Panel, ClinGen" OrgID="509356" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-04-22">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/daeb1902-db11-4ce0-a723-fc1f96265b49</URL>
          </Citation>
          <Comment>NM_000329.3(RPE65):c.1067del (p.Asn356MetfsTer17) is a frameshift variant that introduces a premature stop codon into exon 10 of 14, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant has been reported in at least 2 probands with early-onset severe retinal dystrophy who were compound heterozygous with either the NM_000329.3(RPE65):c.700C&gt;T (p.Arg234Ter) or NM_000329.3(RPE65):c.11+5G&gt;A variants confirmed in trans (2 points, PMID: 9326927, PMID: 37704110), which were previously classified pathogenic by the ClinGen LCA / eoRD VCEP (2 total points, PM3_Strong). At least one proband harboring this variant exhibits a phenotype including a clinical diagnosis of Leber congenital amaurosis (0.5 pts), nystagmus (1 pt), decreased peripheral vision (1 pt), absent or severely decreased rod electroretinogram (ERG) responses (0.5 pts) and abnormal color vision or evidence of cone involvement on ERG (1 pt), which together are specific for RPE65-related recessive retinopathy (4 pts, PMID: 31273949, PP4). In summary, this variant meets the criteria to be classified as pathogenic for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA / eoRD VCEP: PVS1, PM2_supporting, PM3_Strong and PP4. (VCEP specifications version 1.0.0; date of approval 09/21/2023).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen LCAeoRD ACMG Specifications RPE65 V1.0.0</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/f0jffitz/clingen_lcaeord_acmg_specifications_rpe65_v1.0.0.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPE65" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000329.3(RPE65):c.1067del</Name>
            <Name>p.Asn356fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.11:g.68438255del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100368" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>LCA_eoRD VCEP April 2024</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="205122" SubmissionDate="2012-12-20" DateLastUpdated="2014-02-20" DateCreated="2014-02-20">
        <ClinVarSubmissionID localKey="RISN-RPE65:c.1067delA" />
        <ClinVarAccession Accession="SCV000117282" DateUpdated="2014-02-20" DateCreated="2014-02-20" Type="SCV" Version="1" SubmitterName="Retina International" OrgID="500304" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000329.2:c.1067delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Comment Type="public">http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg19&amp;id=RISN_RPE65:c.1060delA</Comment>
        <SubmissionNameList>
          <SubmissionName>RISN_LSDB_112012</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2812897" SubmissionDate="2020-05-26" DateLastUpdated="2020-07-30" DateCreated="2020-07-30">
        <ClinVarSubmissionID localKey="NM_000329.2:c.1067del|MedGen:C1859844" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001425581" DateUpdated="2020-07-30" DateCreated="2020-07-30" Type="SCV" Version="1" SubmitterName="Laboratory of Genetics in Ophthalmology, Institut Imagine" OrgID="507510" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9326927</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPE65" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000329.2:c.1067del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Leber congenital amaurosis 2</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1859844" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7499628</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4086197" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="NM_000329.3:c.1067del|Leber congenital amaurosis" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002092747" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000329.3:c.1067del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Leber congenital amaurosis</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5403483" SubmissionDate="2022-12-14" DateLastUpdated="2022-12-17" DateCreated="2022-12-17">
        <ClinVarSubmissionID localKey="sa_pathology/molecular_pathology_fmc/vc30015" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002761671" DateUpdated="2022-12-17" DateCreated="2022-12-17" Type="SCV" Version="1" SubmitterName="Genetics and Molecular Pathology, SA Pathology" OrgID="506043" OrganizationCategory="laboratory" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPE65" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_13937</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000329.3:c.1067delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100368" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_37</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3107651" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4816104|MedGen:C1859844;C3151086" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001582030" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9326941</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9501220</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9843205</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18632300</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9326927</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn356Metfs*17) in the RPE65 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPE65 are known to be pathogenic (PMID: 9326941, 9501220, 9843205, 18632300). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with autosomal recessive Leber congenital amaurosis (PMID: 9326927). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 98821). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPE65" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.68903931del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1859844" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3151086" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3417557" SubmissionDate="2021-06-16" DateLastUpdated="2021-06-19" DateCreated="2021-06-19">
        <ClinVarSubmissionID localKey="NM_000329.2:c.1067delA|OMIM:204100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001737349" DateUpdated="2021-06-19" DateCreated="2021-06-19" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPE65" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000329.2:c.1067delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="204100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9865170</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5403483" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100368" MappingRef="MONDO">
        <MedGen CUI="CN305526" Name="RPE65-related recessive retinopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9755782" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100368" MappingRef="MONDO">
        <MedGen CUI="CN305526" Name="RPE65-related recessive retinopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3107651" TraitType="Disease" MappingType="XRef" MappingValue="C3151086" MappingRef="MedGen">
        <MedGen CUI="C3151086" Name="Retinitis pigmentosa 20" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3107651" TraitType="Disease" MappingType="XRef" MappingValue="C1859844" MappingRef="MedGen">
        <MedGen CUI="C1859844" Name="Leber congenital amaurosis 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="34239" TraitType="Disease" MappingType="Name" MappingValue="LEBER CONGENITAL AMAUROSIS 2" MappingRef="Preferred">
        <MedGen CUI="C1859844" Name="Leber congenital amaurosis 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4086197" TraitType="Disease" MappingType="Name" MappingValue="Leber congenital amaurosis" MappingRef="Preferred">
        <MedGen CUI="C0339527" Name="Leber congenital amaurosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2812897" TraitType="Disease" MappingType="Name" MappingValue="Leber congenital amaurosis 2" MappingRef="Preferred">
        <MedGen CUI="C1859844" Name="Leber congenital amaurosis 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3417557" TraitType="Disease" MappingType="XRef" MappingValue="204100" MappingRef="OMIM">
        <MedGen CUI="C1859844" Name="Leber congenital amaurosis 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="205122" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

